Related references
Note: Only part of the references are listed.Microlocalization and clinical significance of stabilin-1+ macrophages in treatment-naive patients with urothelial carcinoma of the bladder
Bo Wang et al.
WORLD JOURNAL OF UROLOGY (2020)
SI-CLP inhibits the growth of mouse mammary adenocarcinoma by preventing recruitment of tumor-associated macrophages
Shuiping Yin et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Lymphatic endothelial cells of the lymph node
Sirpa Jalkanen et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Baseline Tumor Size as a Predictive and Prognostic Factor of Immune Checkpoint Inhibitor Therapy for Non-small Cell Lung Cancer
Masahiro Katsurada et al.
ANTICANCER RESEARCH (2019)
Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets
Luca Cassetta et al.
CANCER CELL (2019)
Immunotherapeutic Blockade of Macrophage Clever-1 Reactivates the CD8+ T-cell Response against Immunosuppressive Tumors
Miro Viitala et al.
CLINICAL CANCER RESEARCH (2019)
Tuning the Tumor Myeloid Microenvironment to Fight Cancer
Nadine S. Jahchan et al.
FRONTIERS IN IMMUNOLOGY (2019)
The Role of Stabilin-1 in Lymphocyte Trafficking and Macrophage Scavenging in the Liver Microenvironment
Daniel A. Patten et al.
BIOMOLECULES (2019)
Identification of STAB1 in Multiple Datasets as a Prognostic Factor for Cytogenetically Normal AML: Mechanism and Drug Indications
Sheng-Yan Lin et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
2O Biomarkers of immune switch induced by a novel anti-macrophage antibody (anti-Clever-1 mAb; FP-1305) in MATINS trial patients with advanced solid tumours
M Hollmén et al.
ANNALS OF ONCOLOGY (2019)
Immune checkpoint inhibitors for the treatment of MSI-H/MMR-D colorectal cancer and a perspective on resistance mechanisms
Ibrahim Halil Sahin et al.
BRITISH JOURNAL OF CANCER (2019)
Not CD68 but stabilin-1 expression is associated with the risk of recurrence in patients with oral cavity squamous cell carcinoma
Minsu Kwon et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2019)
Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy
Diego Chowell et al.
SCIENCE (2018)
Recent breakthroughs in metastatic uveal melanoma: a cause for optimism?
Joseph J. Sacco et al.
FUTURE ONCOLOGY (2018)
Macrophage targeting: opening new possibilities for cancer immunotherapy
Luca Cassetta et al.
IMMUNOLOGY (2018)
Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti-PD-1 treatment
Elisa Peranzoni et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies
Laurence Zitvogel et al.
SCIENCE (2018)
The endothelial cell receptor stabilin-2 regulates VWF-FVIII complex half-life and immunogenicity
Laura L. Swystun et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
Peng Jiang et al.
NATURE MEDICINE (2018)
Baseline Tumor Size Is an Independent Prognostic Factor for Overall Survival in Patients with Melanoma Treated with Pembrolizumab (vol 24, pg 4960, 2018)
Richard W. Joseph et al.
CLINICAL CANCER RESEARCH (2018)
Enhanced Antibody Production in Clever-1/Stabilin-1-Deficient Mice
Johannes Dunkel et al.
FRONTIERS IN IMMUNOLOGY (2018)
Immune checkpoint inhibitors: recent progress and potential biomarkers
Pramod Darvin et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2018)
Human Liver Sinusoidal Endothelial Cells Promote Intracellular Crawling of Lymphocytes During Recruitment: A New Step in Migration
Daniel A. Patten et al.
HEPATOLOGY (2017)
Immune checkpoint inhibitors and elderly people: A review
Amaury Daste et al.
EUROPEAN JOURNAL OF CANCER (2017)
Decorin gene upregulation mediated by an adeno-associated virus vector increases intratumoral uptake of nab-paclitaxel in neuroblastoma via inhibition of stabilin-1
Zijun Zhen et al.
INVESTIGATIONAL NEW DRUGS (2017)
Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages
Jennifer L. Guerriero et al.
NATURE (2017)
Immunological tumor status may predict response to neoadjuvant chemotherapy and outcome after radical cystectomy in bladder cancer
Minna Tervahartiala et al.
SCIENTIFIC REPORTS (2017)
Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab
Nadeem Riaz et al.
CELL (2017)
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Padmanee Sharma et al.
CELL (2017)
Monocyte Stabilin-1 Suppresses the Activation of Th1 Lymphocytes
Senthil Palani et al.
JOURNAL OF IMMUNOLOGY (2016)
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
Willy Hugo et al.
CELL (2016)
PI3Kγ is a molecular switch that controls immune suppression
Megan M. Kaneda et al.
NATURE (2016)
Stabilin-1 expression defines a subset of macrophages that mediate tissue homeostasis and prevent fibrosis in chronic liver injury
Pia Rantakari et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Stabilin-1 is expressed in human breast cancer and supports tumor growth in mammary adenocarcinoma mouse model
Vladimir Riabov et al.
ONCOTARGET (2016)
Tumor-Associated Macrophages Provide Significant Prognostic Information in Urothelial Bladder Cancer
Minna M. Bostrom et al.
PLOS ONE (2015)
Clever-1/Stabilin-1 Controls Cancer Growth and Metastasis
Marika Karikoski et al.
CLINICAL CANCER RESEARCH (2014)
Stabilin-2 acts as an engulfment receptor for the phosphatidylserine-dependent clearance of primary necrotic cells
Shilpa D'Souza et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Oncology Meets Immunology: The Cancer-Immunity Cycle
Daniel S. Chen et al.
IMMUNITY (2013)
Recruitment mechanisms of primary and malignant B cells to the human liver
Shishir Shetty et al.
HEPATOLOGY (2012)
Type and location of tumor-infiltrating macrophages and lymphatic vessels predict survival of colorectal cancer patients
Annika Algars et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Stabilin-1/CLEVER-1, a type 2 macrophage marker, is an adhesion and scavenging molecule on human placental macrophages
Senthil Palani et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Deficiency of liver sinusoidal scavenger receptors stabilin-1 and-2 in mice causes glomerulofibrotic nephropathy via impaired hepatic clearance of noxious blood factors
Kai Schledzewski et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Common Lymphatic Endothelial and Vascular Endothelial Receptor-1 Mediates the Transmigration of Regulatory T Cells across Human Hepatic Sinusoidal Endothelium
Shishir Shetty et al.
JOURNAL OF IMMUNOLOGY (2011)
Clever-1/Stabilin-1 regulates lymphocyte migration within lymphatics and leukocyte entrance to sites of inflammation
Marika Karikoski et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Stabilin-1 mediates phosphatidylserine-dependent clearance of cell corpses in alternatively activated macrophages
Seung-Yoon Park et al.
JOURNAL OF CELL SCIENCE (2009)
SPARC in cancer biology: Its role in cancer progression and potential for therapy
Isabella T. Tai et al.
DRUG RESISTANCE UPDATES (2008)
Alternatively activated macrophages regulate extracellular levels of the hormone placental lactogen via receptor-mediated uptake and transcytosis
Julia Kzhyshkowska et al.
JOURNAL OF IMMUNOLOGY (2008)
Stabilin-2 is involved in lymphocyte adhesion to the hepatic sinusoidal endothelium via the interaction with αMβ2 integrin
Mi-Yeon Jung et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Stabilin-1, a homeostatic scavenger receptor with multiple functions
Julia Kzhyshkowska et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2006)
Novel function of alternatively activated macrophages: Stabilin-1-mediated clearance of SPARC
Julia Kzhyshkowska et al.
JOURNAL OF IMMUNOLOGY (2006)
Lymphatic endothelium-specific hyaluronan receptor LYVE-1 is expressed by stabilin-1+, F4/80+, CD11b+ macrophages in malignant tumours and wound healing tissue in vivo and in bone marrow cultures in vitro:: implications for the assessment of lymphangiogenesis
K Schledzewski et al.
JOURNAL OF PATHOLOGY (2006)
Differential lysosomal proteolysis in antigen-presenting CeRs determines antigen fate
L Delamarre et al.
SCIENCE (2005)
CLEVER-1 mediates lymphocyte transmigration through vascular and lymphatic endothelium
M Salmi et al.
BLOOD (2004)
Rapid plasma membrane-endosomal trafficking of the lymph node sinus and high endothelial venule scavenger receptor/homing receptor stabilin-1 (Feel-1/CLEVER-1)
R Prevo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
FEEL-1 and FEEL-2 are endocytic receptors for advanced glycation end products
Y Tamura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The same endothelial receptor controls lymphocyte traffic both in vascular and lymphatic vessels
H Irjala et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
FEEL-1, a novel scavenger receptor with in vitro bacteria-binding and angiogenesis-modulating activities
H Adachi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Analysis of protease activity in live antigen-presenting cells shows regulation of the phagosomal proteolytic contents during dendritic cell activation
AM Lennon-Duménil et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Share Paper
